Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Oncostatin M targeting as approach for treating inflammatory pruritus

Nov. 30, 2021

IL-17A/IL-17RA interaction modulators patented by Janssen Pharmaceutica

Nov. 25, 2021

Chinese researchers synthesize new phosphodiesterase PDE4 inhibitors

Nov. 19, 2021

Vyne reports preclinical data on effect of VYN-201 on skin healing and repair

Nov. 5, 2021

Studies show that psoriasis is more than skin-deep

Nov. 2, 2021

Vyne reports findings with BET inhibitor VYN-201 in animal model and ex vivo human tissue study

Oct. 27, 2021

Titan Pharmaceuticals and MUSC enter research agreement on kappa-opioid receptor agonists

Oct. 14, 2021

Development of cell-penetrating asymmetric siRNAs for treating androgenetic alopecia

Oct. 8, 2021

IL-4 and IL-13 drive atopic dermatitis pathology by regulating sex steroid hormone synthesis

Oct. 4, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents antibodies binding IL-4RA

Sep. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...